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In Brief
The role of extrafollicular B cells in human systemic lupus is unknown. Jenks et al. define the main components of this pathway and its prominence in severe disease. Its activation is mediated by hyper-responsiveness to Toll-like receptor-7 and leads to the generation of autoreactive antibody-secreting plasmablasts.
SUMMARY
Systemic Lupus Erythematosus (SLE) is characterized by B cells lacking IgD and CD27 (double negative; DN). We show that DN cell expansions reflected a subset of CXCR5 -CD11c + cells (DN2) representing pre-plasma cells (PC). DN2 cells predominated in African-American patients with active disease and nephritis, anti-Smith and anti-RNA autoantibodies. They expressed a T-bet transcriptional network; increased Toll-like receptor-7 (TLR7); lacked the negative TLR regulator TRAF5; and were hyperresponsive to TLR7. DN2 cells shared with activated naive cells (aNAV), phenotypic and functional features, and similar transcriptomes. Their PC differentiation and autoantibody production was driven by TLR7 in an interleukin-21 (IL-21)-mediated fashion. An in vivo developmental link between aNAV, DN2 cells, and PC was demonstrated by clonal sharing. This study defines a distinct differentiation fate of autoreactive naive B cells into PC precursors with hyper-responsiveness to innate stimuli, as well as establishes prominence of extra-follicular B cell activation in SLE, and identifies therapeutic targets.
INTRODUCTION
Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple associated autoantibodies. Accordingly, circulating antibody secreting cells (ASC) are prominent in flaring SLE. We reported that a large fraction of these ASC originate from activated naive B cells (aNAV), of distinct phenotype . We also described the expansion of class-switched B cells lacking IgD and the B cell memory marker CD27 (double negative; DN) (Wei et al., 2007) . Similar DN cells have been described as exhausted atypical memory cells in HIV and malaria patients and as anergic naive B cells (Isnardi et al., 2010; Moir et al., 2008) . However, the significance of DN cells remains unclear. Thus, we performed a comprehensive interrogation of these cells in SLE. Our results indicate that the expansion of DN cells in SLE are accounted for by a CXCR5 -CD21 -CD11c + subset (DN2) lacking FCRL4, a marker of atypical memory cells (Ehrhardt et al., 2008) that mediates hypo-responsiveness in HIV infection. DN2 cell expansion was most prominent in African-American patients with high disease activity and nephritis and strongly correlated with anti-Smith and anti-RNA autoantibodies. DN2 cells and aNAV cells shared markers that separated them from other B cells and have a highly similar transcriptomes with high amounts of T-bet and Zeb2. Poised PC differentiation was indicated by phenotypic, functional, transcriptional, and epigenetic data, as well as clonal sharing with circulating plasmablasts (PB). Finally, DN2 cells expressed low amounts of negative TLR regulators including TRAF5. Accordingly, they displayed enhanced responsiveness to TLR7 stimulation. Our work defines a distinct extra-follicular B cell differentiation pathway responsible for the expansion of effector B cells in active SLE. Understanding the antigenic triggers and molecular landscape of DN2 cells should provide pathogenic insight and identify therapeutic targets.
RESULTS
A Subset of IgD -CD27 -B Cells Lacking CXCR5 Is Highly Expanded in SLE DN B cells were studied by flow cytometry in two SLE cohorts. SLE-1 (N = 40; University of Rochester and Johns Hopkins University), included patients with lower disease activity. SLE-2 (N = 50; Emory University), was enriched for higher disease activity and higher serum autoantibodies. Figures 1B and 1C ). DN1 cells, expressing the B cell follicle homing receptor CXCR5 and intermediate amounts of CD19, represented the majority of DN cells in HCD. In contrast, DN2 cells defined by the absence of CXCR5 and CD21 and high CD19, represented the majority of DN cells expanded in SLE (Figures 1B and 1C) . DN2 cells were characterized by high surface expression of the alpha integrin CD11c, primarily expressed in dendritic cells and monocytes, but also found in extra-follicular PB (Racine et al., 2008) and age-associated B cells (ABCs) (Rubtsova et al., 2015) ( Figure 1D ). While DN2 cells were a minor component of CD19 + and DN B cells in HCD, they represented a much higher fraction in SLE where they may account for the majority of non-plasmablast CD19 + B cells (Figures 1E and 1F) . Absolute numbers of DN2 cells were also greatly increased in SLE patients with high DN2 frequency ( Figure 1G ). While DN2 cell frequencies were elevated in some patients with rheumatoid arthritis (RA) and systemic sclerosis, the highest frequency occurred in SLE and was not elevated in primary Sjö gren's syndrome patients ( Figure 1F ).
DN2 Cells Share a Distinct Phenotype with Activated
Naive B Cells DN2 cells were characterized by the absence or low expression of CD24 and CD38 proteins expressed by most human peripheral B cells (Figures 2A and 2B) . DN2 also expressed low amounts of lymph node homing receptor L-selectin (CD62L) and had higher expression of regulatory receptors CD32b and (Siglec-2) CD22. Other proteins with higher expression in DN2 included activation markers CD69, HLA-DR, and CD86. We recently defined a population of activated naive B cells (aNAV), also characterized by high CD19 and loss of CD21, which is expanded in SLE and represents a major source of antibody secreting plasma cells (PC) . aNAV represented the only B cell population sharing multiple DN2 markers, including lack of CXCR5, CD24, and CD38, high expression of CD11c and retention of Mitotracker green (Figures 1D and 2B and 2C) .
Murine CD11c bright ABCs are important for the development of anti-viral IgG2a and autoimmune responses (Rubtsova et al., 2015) . IgG3, the human IgG2a equivalent represents the dominant IgG subclass deposited in lupus kidneys (Zuniga et al., 2003) . DN2 cells expressed mostly sIgG with a higher frequency of IgG3 + cells than SWM or DN1 cells in both HCD and SLE patients ( Figure 2D ). Of note, DN2 cells displayed 50% lower amounts of sIgG ( Figure 2E ). DN2 cells resemble IgD -, CD27
-, CD21-, CD11c + extra-follicular tonsil B cells (Ehrhardt et al., 2008) and similar cells found in RA synovial fluid (Yeo et al., 2015) and in the blood of HIV patients, with the latter representing exhausted memory cells (Moir et al., 2008) . Both tissue-based and exhausted memory B cells are defined by the inhibitory Fc receptor homolog, FCRL4, that impairs exhausted memory B cells (Kardava et al., 2011) . As expected, FCRL4 was expressed in HIV CD21
-DN but not in SLE DN2 cells ( Figure 2E ). However, FCRL5, which is induced by BCR signaling and can drive naive B cell proliferation (Davis et al., 2001; Dement-Brown et al., 2012) , is expressed in SLE DN2 and aNAV B cells. A similar FcRL4/5 pattern has been reported in malaria patients for CD21
À atypical memory cells with impaired proximal B cell signaling (Portugal et al., 2015) . However, as shown in Figure 2G , BCR cross-linking induces substantial BLNK phosphorylation in SLE DN2 cells despite expressing less surface IgG and higher amounts of FCRL5, CD32b, and CD22.
SLE Patients with Increased DN2 B Cells Are
Predominantly African American with Active Disease and anti-smith/RNP and RNA Autoantibodies The highest frequency of DN2 cells was found in the SLE-2 cohort with a predominance of African-American patients (AA) ( Figure 1A ). As shown in Figure 3A , AA patients have a significantly higher frequency of DN2 even in a cohort-independent fashion as it is also observed in SLE-1 despite a predominance of European-American patients. A higher frequency of DN2 cells was present in AA patients with low-medium disease activity relative to non-AA patients (p = 0.0376). In RA patients, the frequency of DN2-like CD11c + ABC B cells increases with age in women (Rubtsov et al., 2011) . We found no age relationship in SLE ( Figure 3B ), where large expansions of DN2 cells were present in young children ( Figure 3C ). The frequency of DN2 cells had modest yet significant correlation with disease activity (Figure 3D) , to a degree commensurate with other immunological variables including plasmablast frequency (Jacobi et al., 2003) . Overall disease activity was higher in patients with expanded DN2 cells and a strong association was present in nephritis patients ( Figure 3D ). Consistent with more active disease, a larger fraction of high DN2 patients were treated with glucocorticoids ( Figure 3E ). DN2 cell frequency was modestly correlated with serum type I interferon activity in both cohorts despite the higher frequency in SLE-2 of AA patients, a population with higher type I IFN activity (Weckerle et al., 2010) (Figure 3F ). Serologically, high DN2 patients had higher titers of anti-RNA antibodies and were much more likely to have antiSm reactivity ( Figures 3G and 3H) . Moreover, using a highly quantitative luciferase immunoprecipitation assay (LIPS) (Ching et al., 2012) , a strong positive correlation was observed with contemporaneous anti-Sm and anti-RNP titers but not other autoantibodies ( Figure 3I ). VH4-34-encoded (9G4 + ) autoantibodies are highly specific for SLE and contribute substantially to dsDNA, Smith and Ro autoantibodies, as well as to anti-lymphocyte and apoptotic cell binding (Richardson et al., 2013; Tipton et al., 2015) . The frequency of 9G4 + cells is increased among aNAV cells in flaring SLE and in global DN cells (Wei et al., 2007) . Consistently, we found in the current study, an increased frequency of 9G4 + B cells in DN2 cells relative to SWM cells and in aNAV relative to resting naive (Figures S1A and S1B). Patients with expanded DN2 cells were also enriched for serum 9G4 + anti-B cell autoantibodies (Richardson et al., 2013) (Figure S1C) . (F) The frequency of DN2 cells in SLE cohorts, rheumatoid arthritis (RA, n = 15), primary Sjö gren's syndrome (pSS, n = 11), and scleroderma patients (SCD, n = 21). Dotted line indicates the mean of the HCD frequency plus 2 SD (4.01%). (G) Absolute number of DN2 cells/ml in SLE patients from cohort 2 with (n = 11) or without (n = 21) DN2 cell expansion. Figure S2B ). PC1 genes highly expressed in SLE included the transcription factors (TF) STAT1 and STAT2 and other interferon regulated genes ( Figure S2C ). The participation of this pathway was supported by the identification by gene set enrichment analysis (GSEA; Figure S2D ) of the overexpression of all three interferon-induced modules defined in SLE mononuclear cells, including IFN-b and IFN-g (Chiche et al., 2014) .
Notably, the SLE B cell transcriptome was enriched for sensors of viral RNA, including TLR7 and IFIH1 ( Figures S2C and  S2D ). Also increased were dsDNA sensors, including inducers of inflammatory pathways of pathogenic relevance for SLE such as the STING inducer TRIM56. SLE B cells also overexpressed the TBK1 kinase that is activated downstream of TLR7 and cytosolic DNA and dsRNA sensors (Kawai and Akira, 2010) .
A minority of DEG were downregulated in SLE B cells including TNF-induced genes such as the negative signaling regulators NFKBIA and TNFAIP3, the latter representing a major SLE susceptibility gene (Musone et al., 2008) (Figures S2C and S2D ). Figures 4A and 4B ). In contrast, over 1,000 DEGs separated DN2 from NAV and SWM cells. PC1 separated DN2 cells from other B cells and PC2 separated NAV B cells from SWM, DN1, and DN2 cells. Reflecting a high content in aNAV cells, NAV B cells from SLE3 had a higher PC1 value and were closer to DN2. This hypothesis was experimentally tested by RNA-seq of the corresponding fractions from additional SLE patients, which demonstrated highly similar transcriptomes of aNAV and DN2 cells ( Figures S4A and S4B) .
Validating the RNA-seq data, there was complete concordance between transcriptional and protein expression of multiple key genes identified by flow cytometry including CD11c, CD86, FCGR2B, FCRL5, and FCRL4.
B cell subpopulations did not differ in their expression of type I IFN receptors and had equal responses to IFN-a ( Figures  S5A-S5F) . Instead, DN2 cells expressed higher type III IFN-l receptor IFNLR1, IL10RA, and IL10RB ( Figure 4C ). Expression of IL-10Ra was verified by flow cytometry ( Figure S5C ) and expression of IL-10R and IFN-lR were confirmed functionally ( Figures  S5D-S5F) . Heightened response to IFN-l and IL-10 was only shared by aNAV cells.
Several informative TF were preferentially expressed in DN2 cells prominently including TBX21 (T-bet) and the T-bet-induced transcriptional regulator ZEB2 ( Figure 4D and Figure S4C ). Flow cytometry confirmed T-bet overexpression in DN2 and aNAV ( Figure 4D ). Moreover, DN2 cells expressed higher amounts of IRF4, a TF essential for PC differentiation (Xu et al., 2015) . An IRF4-induced transcriptome in DN2 cells was also documented by higher expression of genes with binding motifs for IRF4 and its co-factor SPI1 (PU.1) ( Figure 4F ).
The transcriptional identity of DN2 cells was also determined by low transcription of immunologically relevant genes including the sorting marker CXCR5 and other surface markers assessed by flow cytometry including CD24 and CR2. Also, uniquely low in DN2 cells were regulators of TNF receptor-associated factor (TRAF) protein interactions TRAF5, TNFAIP3, and TRAF3IP2. DN2 cells also had low expression of anti-apoptotic BCL2 and ZEB1, a transcriptional regulator whose binding motifs were enriched in genes with low DN2 expression including CXCR5, CD21, and TRAF5 ( Figures 4E and 4F ).
PC2 separated NAV from SWM cells while showing similarity between SWM and DN1 cells. The positive scores for DN2 cells were driven by overexpression of genes including the BLIMP1 repressor BCL6, the inhibitory protein CD72, and the cytokine receptor IL21R ( Figure 4C ). IL21R, critical for naive B cell differentiation, was higher in DN2 cells than in SWM and had the highest expression in NAV and aNAV cells ( Figure S4C ). These differences were confirmed functionally through IL-21-induced STAT3 phosphorylation ( Figure S5B ). However, DN2 cells lacked expression of some genes highly transcribed in NAV cells, namely transcriptional repressors and negative regulators of effector B cell differentiation, including BACH2, FOXP1, BCOR, SPRY, and FOXO1 (Kometani et al., 2013; Rao et al., 2012) . Further reflecting their relatedness with DN2 cells, this pattern was shared by aNAV cells ( Figure S4C ). Genes with higher expression in SWM relative to DN2 cells and NAV B cells included the high-affinity IL-2 alpha receptor (IL2RA; CD25), and the central T cell memory transcription factors TCF7 and RORA (Figures 4C and 4E) .
GSEA analysis ( Figure S3B ) showed that genes enriched in DN2 cells had higher expression in published transcriptomes of NAV B cells, total lupus B cells, and PC. The DN2 B cell transcriptome was also enriched in gene sets from effector memory 
Transcriptional and Functional Analysis Identify SLE DN2 Cells as Precursors of Autoantibody Producing Plasma Cells
Consistent with the enrichment for IRF4-binding motifs, GSEA indicated that, relative to SWM, DN2 cells transcribed higher amounts of IRF4 target genes expressed by PC ( Figure 5A ). This pattern is illustrated by SLAMF7, a lymphocyte activation molecule highly expressed by PC, which is also upregulated by DN2 and aNAV cells but no other B cells ( Figure 5B ). IRF4 and IRF8 reciprocally regulate each other to determine PC versus germinal center fates (Xu et al., 2015) . IRF4 transcription was higher in SLE DN2 cells than in SWM whereas IRF8 expression was lower than in other B cell populations ( Figure 5C ). Also indicative of a PC differentiation fate, DN2 cells expressed low amounts of ETS1 ( Figure 5C ), a TF that represses PC differentiation (Luo et al., 2014) . Finally, expression of PRDM1 (BLIMP-1), an IRF4-induced transcriptional repressor that silences B cell programs and induces PC differentiation (Nutt et al., 2015) , was upregulated in DN2 relative to rNAV cells ( Figure 5C ). In keeping with this pattern, ATAC-seq demonstrated opening of the PRDM1 locus in aNAV and DN2 cells ( Figure S6 ), and flow cytometry demonstrated higher protein expression of BLIMP-1 in aNAV and DN2 cells relative to any other cell types other than PC (Figure 5D ). Flow cytometry also confirmed that DN2 cells and aNAV cells express significantly higher amounts of IRF4 than rNAV and DN1 cells and that the IRF8/IRF4 ratio is significantly lower in aNAV and DN2 cells. This profile is consistent with the promotion of a PC rather than memory fate ( Figure 5E ).
In keeping with a PC differentiation fate, DN2 cell expansions were common in patients with high PC frequencies ( Figure S7A ). Yet, in other conditions, DN2-like cells appeared to poorly differentiate into ASC, typically after BCR and TLR9 stimulation in the absence of exogenous cytokines (Moir et al., 2008; Portugal et al., 2015) . In contrast, we found that DN2 cells were highly responsive to inducers of ASC differentiation including TLR7, IL-21, and IL-10. Indeed, despite lacking significant increase in numbers by day 7, DN2 cells produced higher amounts of IgG on a per cell basis relative to DN1 cells and SWM ( Figure 5F ).
Consistently, ELISPOT readouts identified IgG ASC frequencies higher than rNAV and comparable to SWM and DN1 cells (Figure 5G) . Of note, DN2 cells but not SWM or DN1 cell differentiation was dependent on IL-21 and IL-2 ( Figure 5H ). LIPS measurement of culture supernatants showed that DN2 cells produced anti-Smith, anti-RNP, or anti-Ro antibodies in a pattern consistent with the serological profile of the corresponding patient and in amounts comparable to SWM cells ( Figure 6I ).
BCR sequencing showed that the IgG mutation rate was similar in DN2 cells and PC but lower than SWM ( Figure S7B ). These results strongly argue against direct DN2 differentiation from memory cells or through additional cycles of germinal center maturation of pre-existing memory cells as both paths should result in stable or increased frequency of mutation in DN2 cells, respectively ( Figure S7B ). Bulk sequencing and high throughput single-cell sequencing demonstrated a substantial degree of clonal connectivity between DN2 cells and PC, thereby providing in vivo evidence of PC differentiation from DN2 cells (Figures S7D and S7E) . Similarly, BCR sequencing of aNAV, DN2 cells, and PC showed expanded clones shared between all three populations ( Figure S7F) .
Combined, our studies provide transcriptional, epigenetic, and functional in vitro evidence for the potential of DN2 cells to differentiate into PC, which was in turn corroborated in vivo by extensive BCR repertoire clonal sharing.
DN2 Are Hyper-Responsive to TLR7 but Not CD40 Stimulation DN2 and aNAV cells expressed the lowest amount of TRAF5 ( Figure 4E , Figure S4C ), an essential mediator of CD40 signaling and the main negative regulator of TLR signaling in mouse B cells (Buchta and Bishop, 2014) . Accordingly, CD40L stimulation increased CD25 expression in NAV, but not in DN2 cells (Figure 6A) . In contrast, TLR7 stimulation strongly induced CD25 and ERK and MAPKp38 phosphorylation in DN2 cells but not in other B cells ( Figures 6B and 6C ). TLR7 hyper-responsiveness was shared by aNAV cells (Figures 6C and 6D ). In keeping with enhanced TLR7 responsiveness, R848-stimulated DN2 cells upregulated expression of HLA-DR and CD86 relative to SWM and NAV B cells ( Figure 6E ). In contrast, two negative regulators of B cell receptor signaling, CD72 and CD32b, were downregulated by TLR7 stimulation in DN2 cells, but not NAV B cells. DN2 cells from HCD responded similarly except for CD72 whose expression was unaltered. Please also see Figure S1 . TCF7  CD27  IL6  IL4R  FOXO1  SPRY1  BCOR  FOXP1  BACH2  KLF4  DUSP6  IL21R  BCL6  CD72  IRF8  CD62L  CXCR5  HLADOB  ABLIM_BASP1  CR2  ZEB1  DDR1  JUP_SDK1  INADL  TNFRSF10A  BCL2  TRAF3IP2  TNFAIP3  TRAF5   IL10RA  IRF4  CD22  FCRL3  FCRL5  FCGR2B  DAPP1  SOX5  IFNLR1  TBKBP1  SLAMF7  ZEB2  TBX21 (legend continued on next page) TLR7 and IL-21 Cooperate with IFN-g to Induce Human Naive B Cells Differentiation into DN2 and PC The generation of aNAV and DN2 cells from rNAV B cells was tested under conditions that provide the three categories of signals required for productive B cell activation and differentiation. As combined signal 3 mediators, we selected those inducing hyper-responsiveness of DN2 cells, namely TLR7 and IL-21. Moreover, we included IFN-g given the prominent expression of T-bet and the role of this cytokine in murine TLR7-induced ABCs (Naradikian et al., 2016) . The importance of BCR engagement (signal 1), was tested at different time points as it might be required to trigger naive B cells but might not be necessary for previously activated DN2 cells. We also assessed the role of CD40L (signal 2), as this co-stimulatory signal can inhibit PC differentiation in mice (Randall et al., 1998) and humans (Arpin et al., 1995) and DN2 cells did not respond to CD40L-mediated stimulation ( Figure 6A ).
In the presence of IFN-g and IL-21, TLR7 stimulation of SLE and HCD NAV cells generated PC and non-PC progeny including both aNAV and DN2 cells ( Figures 7A-7D ). Similar cultures showed direct differentiation of aNAV cells into DN2 cells at day 3 and of PC by day 5 ( Figure 7E ). rNAV from SLE and HCD showed an equivalent ability to generate aNAV and DN2 cells and equivalent PC/non-PC ratios at day 7 indicating an unequivocal stimulation pathway ( Figures 7C and 7D ). Activation and/or survival was TLR7 dependent as specific inhibition of TLR7 with ODN 20959 (data not shown) or lack of R848 resulted in almost no viable cells by day 7 (< 5% viability, n = 3; Figure 7F ). Similar to mouse ABC (Naradikian et al., 2016) , the substitution of IFN-g by IL-4 inhibited the generation of aNAV, DN2 cells, and PC (Figure 7A) . Robust PC differentiation also required IL-21, a naive B cell requirement ( Figure 7B ), and this process was inhibited by continuous BCR signaling or CD40L stimulation (data not shown). CD40L stimulation also inhibited differentiation of rNAV into aNAV and DN2 cells but did not impact the generation of DN1 cells. Combined with the transcriptional similarity between DN1 cells and SWM ( Figure 4A ), these results strongly suggest that rather than representing DN2 cell precursors, DN1 cells and DN2 B cells belong in separate differentiation pathways. Finally, based on the molecular data suggesting that DN2 cells are poised to undergo PC differentiation, we determined whether this process could be induced by signals 3 alone. Indeed, as shown in Figure 7F , DN2 cell stimulation through TLR7, IL-21, and IFN-g induced robust PC differentiation in the presence or absence of BCR stimulation. Importantly, PC differentiation required TLR7 as the elimination of R848 resulted in both large increases in cell death and much lower frequencies of PC ( Figure 7F ). Of note, once normalized for cell number, antibody secretion was equivalent in DN2 cells and SWM cultures with R848 ( Figure 7F ). Moreover, PC differentiation was efficiently achieved despite lack of DN2 expansion, indicating that extensive cell division is not required for this process (data not shown). Given that PC differentiation is linked to cell division (Nutt et al., 2015) , our results further support the notion that a PC differentiation program is already engaged in DN2 cells. Stimulation through combined signals 3 was also sufficient to induce differentiation of autoreactive DN2 cells into PC as indicated by production of anti-Ro, anti-RNP, and anti-Smith antibodies at titers comparable to SWM cells ( Figure 7G) .
DISCUSSION
We had shown that a large fraction of the ASCs expanded in active SLE derive from a distinct population of aNAV cells and produce disease autoantibodies even in the absence of somatic hypermutation . We had also described the expansion in SLE of DN B cells expressing switched, mutated antibodies (Wei et al., 2007) . The current study shows that the expansion of DN cells in active SLE is accounted for by distinct DN2 cells that are developmentally related to aNAV cells. DN2 cells are characterized by high expression of CD11c and T-bet; display extra-follicular features, including the absence of CXCR5 and CD62L; and are poised to differentiate into PC. This population is markedly dysregulated and often becomes the predominant B cell population in active SLE, is greatly over-represented in patients with active nephritis, and produces lupus autoantibodies.
Our work identifies the components of the human extra-follicular B cell differentiation pathway through the integration of phenotypic, transcriptional, functional, and repertoire analyses. This approach identifies a developmental link between aNAV and DN2 cells and demonstrates the contribution of this pathway to circulating lupus PB. Moreover, it clarifies the magnitude and the mechanistic basis of enhanced extra-follicular responses in active SLE. The importance of extra-follicular reactions had been well established in mouse models of autoimmunity (Russell et al., 2015; William et al., 2002) but remained unexplored in humans owing to lack of phenotypic identifiers. Further supporting a pathogenic role in human SLE, DN2 cells share the T-bet + CD11c bright phenotype of mouse ABCs, which drive lupus-like autoimmunity in a TLR7-mediated fashion and localize to the T-B cell border (Rubtsova et al., 2017) . While an early study failed to document ABC expansion in SLE (Rubtsov et al., 2011) , SLE is the autoimmune condition with highest frequency of DN2 cells in an age-independent fashion, a pattern also found in a recent study of CD27 low , CD11c
+ ABC-like B cells (Wang et al., 2018) .
CD27
+ T-bet + cells licensed to become PC have also been identified in recall responses as the CD21-activated progeny of memory cells (Lau et al., 2017) . Both populations were postulated to represent reactivated post-germinal center memory cells. Thus, our analysis provides needed discrimination of distinct populations with an overlapping T-bet + , CD11c Please also see Figure S6 and S7.
yet display conserved BCR signaling. Combined, our results suggest that the expression and/or function of inhibitory receptors is impaired in SLE DN2 cells. This model is strongly supported by the overexpression of other inhibitory receptors such as CD22 despite the overall evidence for activation and propensity for PC differentiation. Of particular significance, DN2 cells are defective in the expression of Ets-1, a CD22-regulated TF that prevents PC differentiation (Luo et al., 2014) . Importantly, Ets1 deficiency leads to accumulation of extra-follicular autoreactive B cells (Russell et al., 2015) . (legend continued on next page) SLE DN2 cells and aNAV cells express an effector transcriptional profile and are poised to differentiate into PC. These properties are illustrated by the absence of BACH2, a TF that inhibits terminal differentiation of PC and CD8 + T cells. DN2 cells and aNAV also express the highest amount of T-bet and T-betinduced ZEB2 and lack the T-bet repressor FOXO1. T-bet cooperates with Zeb2 to promote effector cell differentiation through inhibition of TCF7, a TF critical for a central memory fate also expressed by human memory cells (Dominguez et al., 2015) . Hence, we postulate that T-bet and Zeb2 may play a similar role in DN2 B cells which, in contrast to DN1 cells and SWM, express little TCF7. A shared surface phenotype and transcriptome, as well as a lower frequency of SHM, strongly suggest that DN1 cells represent an early SWM precursor that has not yet acquired CD27 expression.
A PC differentiation pathway for DN2 cells is supported by multiple PC markers including SLAMF7 (Lonial et al., 2015) , downregulated sIg, PC differentiation transcriptional programs including silencing of BACH2 (the main negative regulator of PRDM1 transcription), enhanced PRDM1 chromatic accessibility, and BLIMP-1 expression. DN2 cells also display a high IRF4/IRF8 ratio in the absence of Ets1, a pattern that promotes differentiation into extra-follicular PB. In vivo PC differentiation of DN2 cells derived from aNAV cells is documented by clonal inter-connectivity. In all, DN2 cells represent a poised pre-PC stage of pathogenic relevance through the production of disease-related autoantibodies. Thus, as illustrated by anti-SLAMF7 antibodies, (Lonial et al., 2015) , available therapeutic agents could target mature PC, extra-follicular PB and their B cell precursors.
Conclusively establishing a developmental relationship aNAV, DN2 cells and PB can be efficiently generated from naive B cells through TLR7 and IFN-g stimulation in the presence of IL-21. These conditions also generate DN2 cells and PB from aNAV and PB from DN2 cells. Consistent with a poised PC differentiation stage, DN2 cells readily generated PB through signal 3 stimulation provided by TLR7 and IL-21 without the extensive cell division that is obligatory for PC differentiation of follicular B cells (Nutt et al., 2015) or LPS induced murine B cells (Barwick et al., 2016) .
Our studies provide mechanistic insights for SLE. DN2 cells are most prominent in African American patients with severe disease and anti-Sm/RNP antibodies which are genetically linked to susceptibility IRF5 and IRF7 haplotypes (Salloum et al., 2010) . Enhanced responsiveness to TLR7, an innate receptor of central pathogenic significance (Green and Marshak-Rothstein, 2011) , may adversely impact B cell tolerance even at the early transitional stage and facilitate expansion of autoreactive B cells (Giltiay et al., 2013; Kolhatkar et al., 2015) . Chronic TLR7 stimulation is sufficient to induce CD11c + B cells and anti-Sm autoantibodies, whereas B cell-specific TLR7 deficiency decreases CD11c + B cells and prevents lupus-like disease (Jackson et al., 2014) . In keeping with those studies, SLE DN2 cells displayed enhanced TLR7 signaling and TLR7-mediated activation, downregulation of inhibitory receptors (e.g., CD72) and increased expression of co-stimulatory molecules, generation of anti-Sm/RNP autoantibodies, and DN2 cell frequencies correlated with anti-Sm/RNP and anti-RNA serum titers. As immune complexes, these autoantibodies are a major source of exogenous RNA, leading to the stimulation of endosomal TLR7, a process that may be inhibited by CD72 (Akatsu et al., 2016) . TLR7 hyper-responsiveness would be enhanced by defective expression of TRAF5 (Buchta and Bishop, 2014) . In addition, DN2 cells are defective in other negative regulators of pro-inflammatory responses to TNF and TLR, two major pathogenic pathways in SLE, including NFKBIA and TNFAIP3, and other regulators of innate sensing pathways including TRAF5 (TLRs) and TRAF4 (NOD2). Combined with overexpression of other dsRNA and DNA sensors, our results suggest that SLE DN2 B cells may be dysregulated through exaggerated innate stimulation coupled to defective negative regulation of effector pro-inflammatory pathways. Notably, DN2 cells and aNAV cells are hyper-responsive to IFN-l, a poorly understood type III IFN implicated in lupus nephritis (Zickert et al., 2016 ) that enhances B cell TLR7 expression and responses (de Groen et al., 2015) . A predominant role of IFN-l would be consistent with the weak correlation between serum type I IFN activity and DN2 cell frequency and would identify a therapeutic target not covered by current anti-IFN strategies.
In sum, the present study establishes the prominent participation in SLE of a distinct extrafollicular differentiation pathway that ensues from naive B cells and generates autoreactive PC. Together with our previous work, it demonstrates a prominent role for ongoing activation of naive B cells in the generation of SLE autoantibodies despite long-standing B cell memory of similar autoreactivity. Our work also provides insight into the molecular underpinnings of abnormal DN2 cell responses thereby opening avenues for different therapies, segmentation, monitoring, and outcome measurements in SLE.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (E) Direct differentiation into DN2 cells starting from rNAV or aNAV in 3 day cultures using similar stimulation as before (left and middle). aNAV cells generated significantly more DN2 cells in either HCD (n = 1) or SLE (n = 3) than rNAV. Day 5 cultures started with aNAV cells (2 HCD and 2 SLE; right) contained significantly higher frequencies of PC (Mann Whitney test). (F) DN2 cell cultures have an equivalent ability to generate PC as SWM and DN1 cell cultures and are superior to rNAV cultures (HCD = open circles; SLE = shaded circles). Representative examples are shown for HCD and SLE (n = 4). TLR7 stimulation, tested by excluding R848 was essential for DN2 cell to PC differentiation (tested in SLE only; bottom left). When normalized to cell number the IgG output of DN2 cell cultures were equivalent to SWM and DN1 cell cultures and superior to rNAV in both HCD and SLE cells (bottom right; Welch's t test).
(G) LIPS analysis of day 7 culture supernatants from two patients with Ro, SmD, and RNP autoantibody titers. Table S1 . An additional 22 SLE patients with active nephritis (biopsy confirmed nephritis within 1 month or current proteinuria with past biopsy confirmed nephritis) were also recruited. The RNA Seq experiments described in Figure 4 , Figure 5 , and Figure S2 were performed on B cells from 3 female SLE patients and 2 female HCD and 1 male HCD. The RNA Seq data shown in Figure S4 are from 8 female SLE patients. Sample sizes can be found referenced within the legends of individual figures for summary experimentation.
METHOD DETAILS
Flow cytometry and cell sorting Peripheral blood mononuclear cells (PBMC) were isolated using either sodium heparin tubes stored overnight followed by Ficoll gradient isolation (Cohort 1) or sodium heparin CPT Tubes isolated on the same day (Cohort 2). For in vitro stimulation of sorted HCD DN2 cells, 500 mL of blood was spun at 2,500g for 5 minutes, the plasma layer was removed, and PBMC were isolated from the buffy coat by Ficoll gradient. . Antibodies and fluorochromes utilized are listed in Table S2 and the key resources table. Cells were stained at the manufacturers recommended concentration with 10% normal mouse serum to block Fc receptor and non-specific binding. Anti-mouse beads (Bangs) single stained with each fluorochrome were used for compensation. Intracellular staining was done using True-Nuclear Transcription Factor Buffer Set (Biolegend) for fixation and permeabilization. Ex vivo binding of 9G4 + antibodies to B cells was quantified by staining with 9G4 Pacific Blue (custom labeled) and comparing the median fluorescence intensity of resting naive and switched memory B cells. Flow cytometry data was analyzed using the FlowJo software (Treestar).
Phosphorylation by flow cytometry Cell signaling was analyzed after 5 minutes stimulation with 10 mg/ml goat F(ab')2 anti-human IgG (Southern Biotech) for BCR signaling or 15 minutes with 100 ng/ml Interferon Lambda 1 or Interferon Alpha or the indicated doses of IL-10 or IL-21 (R&D) for cytokine receptor signaling or the indicated dose of R848 (Invivogen) for TLR7 signaling. Following stimulation cells were fixed with 1.6% paraformaldehyde for 5 minutes and then permeabilized with 90% ice cold methanol (STAT staining) or 70% ice cold methanol (non-STAT staining) and stored at À20 C until staining with the antibodies listed in Table S2 . Because CD21 and CXCR5 staining do not survive methanol permeabilization, DN2 cells and aNAV were gated on CD11c ++ CD20 bright. Phosphorylation was analyzed using both FlowJo and Cytobank software. Signaling was expressed as the fold increase in median fluorescence intensity over unstimulated controls. 
RNA sequencing

RNA Sequencing Analysis
Reads were mapped to the human genome (hg19) with TopHat 2.0.13 using default parameters. The aligned reads were transformed with SAMtools to quantify number of reads at the gene level with HTSeq-0.6.1 using default ''union'' mode. Raw counts were compiled to identify differentially expressed genes with edgeR within the SARTools R pipeline, using TMM normalization and Benjamini-Hochberg for false discovery rate. Statistical analysis and plotting were performed using the R software v.3.2, and NMF R package was used to draw heatmaps. Transcripts are expressed at reads per kilobase per million (RPKM), genes that showed at least a two-fold difference and a false discovery rate (FDR) of < 0.05 were considered differentially expressed. The RNA sequencing analyis shown in Figure S4 was analyzed as previously described (Barwick et al. 2018 ) with minor modifications.
Gene Set Enrichment Analysis (GSEA) GSEA was done using javaGSEA through the Broad Institute. For each comparison, all expressed genes were ranked by t-statistic and preranked analysis was used to look at enrichment in the Broad Institute c2: curated gene sets and c7: immunological signature gene sets, and the 3 sets of interferon regulated genes previously examined in SLE (Chiche et al., 2014) . Gene sets with less than 15 or more than 500 genes were excluded. A FDR of 0.05 was used as a cut off for enrichment. Only select enriched pathways are shown.
Transcription factor binding motif analysis
The iRegulon (Janky et al., 2014 ) application for Cytospace was used for transcription factor binding using the default settings. Based on the principal component analysis, genes with high or low expression in SLE B cells and genes with high or low expression in DN2 cells were used as input gene lists. These genes lists were then analyzed to determine what known and predicted transcription factor binding motifs are enriched, which transcription factors bind these motifs, and which genes in the list have the motif
In vitro stimulation
To test changes in cell surface staining after TLR7 stimulation total B cells were purified from PBMCs by negative selection using magnetic microparticles (StemCell Technologies) and cultured overnight with the indicated doses of R848 in RPMI plus 10% FBS at 37 C in 5% CO2. Because of overnight changes in surface expression, SWM were gated based on IgD-and DN2 cells based on IgD-, CD11c bright, and CD19 bright. To test antibody production, sorted B cells were plated at 20,000-30,000 cells/well in 200 mL RPMI plus 10% FBS stimulated with 1.25 mg/ml R848 (Invivogen), 10 mg/ml goat F(ab')2 anti-human IgG (Southern Biotech), and the following recombinant cytokines (R&D); 50 ng/ml IL-2, 100 ng/ml IL-21, 250 ng/ml IL-10, and 100 ng/ml BAFF.
Stimulation of B cells under Th1 conditions used the following TLR (Invivogen) and cytokine stimuli (Biolegend) in RPMI+10% FBS supplemented with non-essential amino acids, glutamine, sodium pyruvate, and Primocin (Invivogen); R848 1 mg/ml, BAFF 10 ng/ml, IL-21 10ng/ml, IL-2 50 units/ml and IFN-g 20ng/ml, with or without 10 mg/ml goat F(ab')2 anti-human IgG and IgM for 3 days, cells were then washed and resuspended in fresh media with R848 and cytokines but not anti-IgG and IgM. After 4 additional days (Day 7) cells were counted and, in some experiments plated for ELISPOT, and in others stained for flow cytometry with CD19, IgD, CD27, CD11c, CD21, and CD38 to determine plasma cell differentiation. Cultures may have been initiated with different starting sorted B cell populations and could lack BCR or TLR depending on the questions trying to be addressed. These data representing these cultures will be clearly labeled within their respective figure legends. Supernatants were tested by total IgG ELISA and LIPS assay for autoantigens.
Anti-RNA ELISA Modified from a protocol generously provided by the laboratory of Mark Shlomchik. Nunc Polysorp flat-bottom plates (Thermo Scientific) were coated overnight at 4 C with poly-L-lysine (Sigma), followed by a 1 hr incubation with 15 mg/mL yeast RNA (Sigma) followed by blocking for 1 hour with PBS+1%BSA. Plates were then washed again, followed by an incubation with 1:10 diluted patient serum samples for 1 hr at room temperature and then washed. Goat anti-human (Fc specific) IgG-AP (Sigma) secondary antibody was then added for 1 hour at room temperature. After washing the KPL BluePhos Microwell Phosphatase Substrate system was utilized according to manufacturer's specifications (Sera Care).
IgG ELISA Costar Assay plate high binding plates were coated overnight at 4 C with 2 ug/ml Goat Anti-Human IgG, F(ab') 2 fragment specific in PBS and then washed with PBS 0.1% Tween-20 and blocked with Super Block Blocking Reagent for 45 minutes. Plates were next incubated with culture supernatants and human IgG whole molecule standard for 60 minutes. Bound antibodies were then detected with 1:15,000 secondary Fc specific goat anti-human IgG-alkaline phosphatase (Sigma) followed by chromogenic detection with KPL BluePhos Microwell Phosphatase Substrate.
IgG ELISPOT
MultiScreen-IP sterile filter plates (EMD Millipore) were first wetted with 15 mL 35% ethanol and immediately washed 3 times with sterile H20 and then coated with 5 mg/ml goat anti-human IgG (Bethyl) in PBS overnight at 4 C. Plates were then washed and blocked with RPMI+10% FBS at 37 C for 60 minutes and serially diluted B cells were incubated in RPMI+10% FBS 12-16 hours. After washing IgG was then detected with 1 mg/ml goat anti-human IgG-alkaline phosphatase (Bethyl) and spots were visualized using Vector Blue Alkaline Phosphatase Substrate and quantified using an automated CTL ELISPOT reader.
Interferon Alpha assay activity Epithelial derived WISH cells were used as an Interferon Alpha reporter cell line and incubated at 5x10 5 cells/ml with 50% patient serum in Minimal Essential Medium supplemented with 10% FBS, 10 mM HEPES, 2 mM L-glutamine and penicillin-streptomycin for 6 hours at 37 C. After 6 hours, cells were lysed, RNA isolated and cDNA made from total cellular mRNA and Interferon Alpha induced transcripts MX1, PKR, and IFIT1 were quantified by reverse transcriptase-PCR. Relative expression was normalized and presented as an INF-a activity score.
Transcription factor binding motif analysis The iRegulon (Janky et al., 2014 ) application for Cytospace was used for transcription factor binding using the default settings. Based on the principal component analysis, genes with high or low expression in SLE B cells and genes with high or low expression in DN2 cells were used as input gene lists. These genes lists were then analyzed to determine what known and predicted transcription factor binding motifs are enriched, which transcription factors bind these motifs, and which genes in the list have the motif. Only the top binding transcription factors with significant enrichment are reported.
Luciferase Immunoprecipitation Systems (LIPS)
LIPS was performed in a 96-well plate format by incubating cell culture supernatant with Renilla luciferase (Ruc)-antigen fusion protiens to the SLE auto-antigens Smith-D, Ro-60, and RNP-U1 (gift of M. Iadarola) for 30 minutes. The antibody-antigen mixture was then captured by proteinA and G beads in a 96-well filter plate. After washing, antibody bound Ruc-antigen is measured using coelenterazine substrate and light units were measured in a Berthold LB 960 Centro luminometer.
ATAC-seq preparation and analysis ATAC-seq was performed on 10,000-50,000 FACS isolated cells as previously described in detail (Scharer et al., 2016a .4], 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630) and centrifuged for 30 min at 500xg at 4 C to isolate nuclei. Nuclei were transposed in 25 mL tagmentation reaction buffer (2.5 mL Tn5, 1x Tagment DNA Buffer) and incubated for 1 hr at 37 C. Next, transposed nuclei were lysed with 25 mL 2x Lysis Buffer (300cmM NaCl, 100cmM EDTA, 0.6% SDS, 1.6cmg Proteinase-K) for 30 min at 40 C, low molecular weight DNA purified by size-selection with SPRI-beads (Agencourt), and PCR amplified using Nextera primers with 2x HiFi Polymerase Master Mix (KAPA Biosystems). Amplified, low molecular weight DNA was isolated using a second SPRI-bead size selection. Libraries were sequenced using a 50bp paired-end run at the NYU Genome Technology Center. Raw sequencing reads were mapped to the hg19 version of the human genome using Bowtie and peaks called using MACS2 (Scharer et al., 2016a) . Data display and peak quantitation performed using the R/Bioconductor package and custom scripts that are available upon request.
Sample preparation and Illumina MiSEQ sequencing for repertoire analysis RNA was extracted from lysed samples by following the quick start protocol from QIAGEN's RNeasy Mini Kit. Subsequently, firststrand cDNA synthesis was performed using the iScript cDNA synthesis kit and 8ul of RNA following manufacturer's recommended protocol. First-round amplification of IgG, IgA, and IgM was performed in a 25ul reaction volume using 4ul of cDNA, 20ul Platinum PCR SuperMix High Fidelity (Invitrogen), and 1ul gene specific primers (120nM). PCR1 conditions were as follows: 95 C for 3 minutes; 40 cycles of:30 s 95 C, 30 s 58 C, 30 s 72 C; and 72 C for 5 minutes. Samples were then ligated in a second-round PCR with Nextera Index kit (Illumina). PCR2 conditions for this reaction were as follows: 72 C for 3 minutes; 98 C for 30 s; and 5 cycles of:98 C for 10 s, 63 C for 30 s, and 72 C for 3 minutes. Products was then purified with Agencourt AMPure XP beads (Beckman Coulter). Purified samples were run on 1.2% agarose gels (Lonza) to verify amplification. Libraries were prepared for MiSEQ sequencing by denaturing sample using 0.2N NaOH and quenching the reaction with cold HT1 according to manufacturer's workflow (Illumina). Denatured libraries were combined with 20% PhiX (Illumina) as an internal quality control, then loaded onto a 600-cycle V3 MiSEQ cartridge (Illumina). Emulsion single cell PCR was done on either freshly isolated CD27 2+ CD38 2+ plasma cells or DN2 cells stimulated under the conditions described above for 7 days. B cells were resuspended in PBS (aqueous phase) at a concentration of 100,000/ml and were then passed through the innermost needle of 26-gauge diameter of the flow focusing device at flow rate of 500 mL/min. Then, 45 mL/ml poly(dT) magnetic beads per ml of the cell solution were pelleted using a magnetic strip and fully resuspended in cell lysis buffer (100 mM Tris pH 7.5, 500 mM LiCl, 10 mM EDTA, 1% lithium dodecyl sulfate and 5 mM DTT) and kept on ice. Beads in lysis buffer (aqueous phase) are passed through the 19-gauge outer hypodermic needle at flow rate of 500 mL/min and the oil phase with surfactants (molecular biology grade mineral oil containing 4.5% Span-80, 0.4% Tween 80 and 0.05% Triton X-100, v/v% was passed through the outermost glass tubing with nozzle (diameter 150 mM) at a flow rate of 3ml/min. The emulsion stream were then serially collected in 2ml centrifuge tubes and kept at room temperature for 2 minutes and then kept on ice for 20 minutes. After 20 minutes, all the tubes were pooled together in 50 mL conical tube and centrifuged at 4000g for 5 min at 4 C. Top layer containing oil and smaller emulsions was discarded and the remaining emulsion pellet was broken by adding equal volume of ice cold water saturated diethyl ether. This solution was then centrifuged again at 4000g for 6 min at 4 C. Supernatant was carefully aspirated leaving the polydT magnetic beads pellet undisturbed and the pellet was resuspended in 1ml of cold wash buffer 1 (100 mM Tris pH 7.5, 500 mM LiCl and 1 mM EDTA), washed, pelleted again and resuspended in 2ml of cold lysis buffer. Beads were pelleted again, washed and resuspended in 1ml of wash buffer 1, pelleted and resuspended in 500 mL of wash buffer 2 (20 mM Tris pH 7.5, 3mM MgCl and 50 mM KCL). Beads were pelleted and finally resuspended in cold OE RT-PCR mix. The resulting bead mix was emulsified in IKA dispersing tube, plated on 96 well PCR plate, thermocycled RT-PCR. cDNA was extracted and nested PCR was performed as preciously described. The nested PCR products were purified by gel extraction to extract > 850 bp product and sequenced on Illumina platform (2X300 cycles).
QUANTIFICATION AND STATISTICAL ANALYSIS
Flow cytometry analysis All dot plots or contour plots were plotted in FlowJo v.9 or v.10 software (Treestar) whereas histograms were generated in either FlowJo or Cytobank softwares.
Statistical Analysis
Graphpad Prism version 7 software was used for statistical analysis. Multiple groups from the same patient were compared using repeated-measure one-way ANOVA and the Mann Whitney test or Welch's t test were used to compare unmatched samples. The Holm-Sidak correction was utilized for multiple comparisons and the adjusted P value are indicated as * p < 0.05, ** p < 0.01, *** p < 0.001. Fischer's exact test was used for contingency tests and Spearman's Rank-Order correlation for correlation. All error bars show the mean ± standard deviation DATA AND SOFTWARE AVAILABILITY RNA-Seq Raw sequences and normalized gene expression data are currently available at the Gene Expression Omnibus, with the accession number for the data listed as: GSE92387
Ig-Seq
IgSeq software for repertoire analysis is available upon request.
